NovoLog is a prescription medication used to control blood sugar levels in people with type 1 and type 2 diabetes. The rapid-acting insulin, which is injected 5 to 10 minutes before you start eating, is designed to help control the blood sugar spike that occurs after meals. Potential side effects of NovoLog include injection site skin reactions and low blood sugar levels.
What Is NovoLog?
NovoLog® (insulin aspart) is a prescription form of insulin used to treat type 1 diabetes and type 2 diabetes. It is a rapid-acting insulin, used to help control the spike in blood sugar that occurs after meals. It is typically used in combination with a long-acting insulin. NovoLog can also be used in an insulin pump and can be given intravenously (by IV).
NovoLog is a form of insulin, which is a hormone that is naturally produced by the pancreas. This hormone is important for several functions, such as controlling blood sugar. Insulin helps the cells of your body remove glucose ("sugar") from your bloodstream. This sugar fuels your body's cells, giving them the energy they need to work properly. You may need to take insulin if your pancreas has trouble making enough insulin, which is the case in people with type 1 diabetes and in some people who have type 2 diabetes.
Normally, your body is able to maintain proper levels of sugar in your blood and inside your cells. However, in people with type 1 diabetes (and sometimes type 2 diabetes), the pancreas has trouble making insulin. This causes too much sugar to accumulate in the blood. Too much sugar can also accumulate in the blood if your body has trouble responding to normal levels of insulin, as is common in type 2 diabetes. Over time, high levels of sugar in the blood can lead to serious health problems in the eyes, feet, hands, kidneys, and heart.
NovoLog is a rapid-acting insulin medication. It starts working quickly, produces a sharp peak in insulin levels, and drops off quickly. It is designed to help control the blood sugar spike that occurs after meals. Most people who take NovoLog will also need a long-acting insulin in addition to NovoLog to provide a steady background level of insulin to help control blood sugar throughout the day.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
NovoLog [package insert]. Plainsboro, NJ: Novo Nordisk;2013 October.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed May 6, 2008.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 7th ed. Philadelphia (PA): Lippincott Williams & Wilkins;2005.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click